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Abstract 
Introduction: Diarrhoea remains a major cause of illness in Papua New Guinea (PNG); however, little is known about its aetiology. As a 
result of the cholera outbreak that spread throughout PNG in 2009-2011, we conducted diarrhoeal surveillance in Eastern Highlands 
Province. 
Methodology: Following informed consent and a brief questionnaire, participants provided a stool sample or duplicate rectal swabs. Samples 
were tested for common bacterial pathogens Salmonella spp., Shigella spp., Vibrio spp., Campylobacter spp. and Yersinia enterocolitica 
using established culture methods. Enteric parasites were detected using microscopy.  
Results: A total of 216 participants were enrolled; where age was recorded, 42% were under 5 years of age, 6.7% were 5 to 17 years of age 
and 51.3% ≥18 years of age. One or more pathogens were detected in 68 (31.5%) participants, with Shigella (primarily S. flexneri) being the 
most commonly isolated (47 of 216 participants). Enteric parasites were detected in 23 of the 216 participants, occurring as a co-infection 
with another pathogen in 12 of 23 cases. No Vibrio cholerae was detected. Shigella isolates were commonly resistant to ampicillin, 
tetracycline, co-trimoxazole and chloramphenicol. 
Conclusions: Shigellae, specifically S. flexneri, are important pathogens in the highlands of PNG. While most studies in low-income settings 
focus on childhood aetiology, we have demonstrated the importance of Shigella in both children and adults. Enteric parasites remain present 
and presumably contribute to the burden of gastrointestinal illness. While improvements in sanitation and hygiene would help lower the 
burden of all aetiologies of infectious diarrhoea, additional control strategies targeting Shigella may also be warranted. 
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Introduction 
The global burden of enteric diseases remains 
unacceptably high, despite improvements in recent 
years. Diarrhoea remains the second leading cause of 
mortality in children under the age of 5 years with the 
burden greatest in low-income settings [1], where poor 
sanitation, hygiene and food safety facilitate the spread 
of enteric pathogens. A recent multi-centre case-
control study found rotavirus, Cryptosporidium, 
enterotoxigenic Escherichia coli and Shigella spp. to 
have a significant association with moderate-severe 
diarrhoea in children at all study sites [2]. The findings 
may be indicative of the aetiology of enteric illness in 
many low-income settings; but regional variations in 
diarrhoeal aetiology are known to occur, as recognized 
in the multicentre study [2]. Such studies are valuable 
and set the framework for global research and 
intervention priorities, but do not negate the need for 
country specific data.  
In Papua New Guinea (PNG), government and 
non-government organisations quote figures that 
suggest diarrhoea and other enteric illness (primarily 
typhoid fever) remain amongst the most important 
causes of morbidity and mortality [3,4]. However, the 
current data are weak as there have been very few 
studies conducted in recent times investigating the 
aetiology of diarrhoea in PNG. The most recent 
comprehensive data in PNG comes from a study 
conducted in children in 1985-1990 [5]. More recently 
Horwood and colleagues conducted rotavirus 
surveillance in children hospitalized with acute watery 
diarrhoea in the highlands of PNG. Rotavirus was 
detected in 31.2% of study participants, demonstrating 
its importance in childhood gastroenteritis. However, 
other causes of diarrhoea were not sought [6]. 
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Globally most studies focus on childhood 
diarrhoea, as the burden of disease and the potential 
for severe negative outcomes is greatest in this age 
group (< 5 years). However, diarrhoeal illnesses also 
affect adults, and the all-age global burden of 
diarrhoea is considerable [7,8]. Recent outbreaks of 
shigellosis [9] and cholera [10,11] in PNG have 
demonstrated the impact diarrhoeal diseases can have 
on the adult population. The recent cholera epidemic 
was the first outbreak of this disease in PNG and the 
response at the national level was hampered by a lack 
of diagnostic capacity [12]. As part of the response to 
the cholera outbreak, we conducted surveillance of 
diarrhoea in children and adults in the Eastern 
Highlands of PNG at a time when sporadic cases of 
cholera had been reported in highland provinces. 
 
Methodology 
Informed Consent, Recruitment and Sample Collection 
Adults and children presenting to Lopi Urban 
Clinic and Goroka General Hospital out-patients with 
self-reported diarrhoea were invited to participate in 
the study. The study was approved by the PNG 
Institute of Medical Research Institutional Review 
Board (IRB 0926) and the PNG Medical Research 
Advisory Committee (MRAC 10.09). Following 
informed consent, participants were interviewed and a 
questionnaire completed by research staff. The 
questionnaire provided demographic information for 
each participant. When possible a stool sample was 
provided: if the patient was unable to provide a stool 
sample duplicate rectal swabs were collected. Rectal 
swabs were placed into Cary-Blair transport medium 
and stool samples were collected in stool specimen 
jars. All specimens were held at room temperature 
until they could be transported to the laboratory 
(within 4 hours of sample collection). 
 
Detection of pathogens 
Upon arrival at the laboratory specimens were 
processed immediately. Culture was conducted for the 
bacterial pathogens, specifically targeting Salmonella 
spp., Shigella spp., Vibrio spp., Yersinia enterocolitica 
and Campylobacter spp. MacConkey agar, Xylose 
Lactose Desoxycholate (XLD) agar, thiosulphate 
citrate bile salts sucrose (TCBS) agar, Yersinia 
selective agar (with cefsulodin 15mg/l, Irgasan 4 mg/l 
and novobiocin 2.5 mg/l) and Campylobacter blood-
free selective agar with CCDA selective supplement 
(cefoperazone 32 mg/l and amphotericin B 10 mg/l) 
(Thermo Fisher Scientific, Scoresby, Australia) were 
used for the selective isolation of the targeted bacterial 
pathogens. Following inoculation of plates, a small 
portion (~1 g) of stool, or the swab that had been used 
to inoculate the agar plates, was placed into mannitol 
selenite cysteine broth and incubated at 37°C for 18-24 
hours to enrich for Salmonella spp. The enrichment 
broth was then plated onto XLD agar. All plates were 
incubated at 37°C for 24 hours initially, and a further 
24 hours if required. Campylobacter plates were 
incubated under microaerophilic conditions 
(CampyGen, Thermo Scientific, Scoresby, Australia); 
all other plates were incubated aerobically. 
Biochemical tests were conducted on suspect 
colonies using standard procedures [13] and, where 
necessary, confirmed using the Crystal biochemical 
profiling system (BD Pty Ltd, Sydney, Australia). 
Suspected isolates of Shigella and Salmonella were 
confirmed by real-time PCR [14-16] and polyvalent 
antisera when available (Remel, Thermo Scientific, 
Scoresby, Australia). 
An iodine-stained wet prep was viewed under a 
microscope to detect parasites according to standard 
techniques [17]. When available a portion of a stool 
sample was used; or alternatively the second of the 
two rectal swabs provided. Entamoeba histolytica was 
differentiated from Entamoeba coli on the basis of cyst 
size using a calibrated graduated eye piece. 
 
Antibiotic Susceptibility Testing 
Antibiotic susceptibility testing was conducted 
using the Kirby-Bauer disk diffusion method on all 
isolated bacterial pathogens. Isolates were tested for 
susceptibility/resistance to ampicillin, 
chloramphenicol, ciprofloxacin, ceftriaxone, nalidixic 
acid, co-trimoxazole and tetracycline, following 
appropriate guidelines [18]. Isolates were preserved in 
skim milk glucose glycerol broth and stored at -80°C. 
At a later date viable isolates were resuscitated and the 
minimal inhibitory concentration (MIC) was 
determined using E-test strips (BioMérieux, Baulkham 
Hills, Australia). 
 
Data Entry and Analysis 
Data were entered into Microsoft Excel (Microsoft 
Corporation, Redmond, USA) and analysis conducted 
using Excel and SPSS Statistics 20 (IBM Corporation, 
Armonk, USA).  
 
Results 
A total of 216 samples were collected from 
October 2010 to August 2011 and included in analysis. 
Age was recorded for 195 of the 216 participants, with 
approximately half being adults and half under the age 
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of 18 years. Males more commonly presented than 
females. The age and sex distributions are shown in 
Table 1. Of the 195 participants whose age was 
recorded, one or more pathogens were detected in 66 
participants: 43 of 100 (43%) adult participants; 4 of 
13 (30.8%) in the 5 to 17 years of age group; and 19 of 
82 (23.2%) in children under 5 years of age. The rate 
of pathogen isolation differed significantly between 
adults and all children (≤ 17) (χ2 = 7.682, degrees 
freedom 1, p = 0.005) and adults and children less than 
5 years old (χ2 = 7.887, degrees freedom 1, p = 0.005). 
Pathogens were isolated from 68 of 216 (31.5%) 
study participants (66 pathogens from people with age 
recorded and an additional 2 pathogens from 
participants without age recorded): 55 participants had 
a single pathogen isolated and 13 had two or more 
pathogens isolated. Shigella spp. were the most 
common pathogen isolated, being present in 47 
(21.8%) samples. Of the 47 Shigella isolates, 32 were 
speciated by serology: the majority (30/32) were S. 
flexneri and the remaining two were serologically 
confirmed as isolates of S. dysenteriae. Five samples 
(2.3%) were culture positive for Salmonella enterica 
serovar Typhi. No other bacterial pathogens were 
detected. Entamoeba histolytica (n = 15; 6.9 %), 
Blastocystis hominis (n = 10; 4.6%) and Giardia 
lamblia (n = 7; 3.2%) were the most commonly 
detected parasites. Table 2 provides a summary of the 
detection of pathogens. 
Patients self-reported on the characteristics of their 
stools in the days leading up to presentation. Of the 
216 patients in the study, 61 reported blood in their 
stools and 81 reported having mucus present. Patients 
with confirmed shigellosis or amoebiasis were more 
likely to report having had blood in their stools than all 
other patients, although the difference was not 
significant to the P < 0.05 level (P = 0.098). No 
relationships were observed for the self-reported 
presence of mucus in stools. Patients who reported 
having diarrhoea for at least 1 week were more likely 
Table 1. Age and sex distribution of study participants that had both data recorded (195 of 216 participants). 
 
< 5yrs 5 - 17 years ≥ 18years 
N (%) 82 (42%) 13 (6.7%) 100 (51.3%) 
Sex (M:F) 44:35* 7:6 66:34 
*Sex was not recorded for 3 children <5 years old. 
 
 
Table 2. Detection of enteric pathogens, with percentage prevalence in parenthesis, according to age group in the highlands of 
Papua New Guinea. 
Pathogen 
< 5 years 
n = 82 
5 – 17 years 
n = 13 
≥18 years 
n = 100 
Total 
n = 216* 
Shigella flexneri 6 (7.3) 2 (15.4) 22 (22) 30 (13.9) 
Shigella dysenteriae 1 (1.2) 0 (0) 1 (1) 2 (0.9) 
Shigella (not typed) 9 (11.1) 0 (0) 5 (5) 15† (6.9) 
Salmonella Typhi 1 (1.2) 1 (7.7) 2 (2) 5† (2.3) 
Entamoeba histolytica 1 (1.2) 1 (7.7) 13 (13) 15 (6.9) 
Blastocystis hominis 1 (1.2) 0 (0) 9 (9) 10 (4.6) 
Giardia lamblia 2 (2.4) 1 (7.7) 4 (4) 7 (3.2) 
Ascaris lumbricoides 0 (0) 0 (0) 1 (1) 1 (0.5) 
Hookworm 0 (0) 0 (0) 1 (1) 1 (0.5) 
Multiple pathogens 1 (1.2) 1 (7.7) 11 (11) 13 (6.0) 
*Includes participants whose age was not recorded; †One additional Shigella sp. isolate and one additional S. Typhi isolate from study participants who did 
not have age recorded.  
 
Table 3. Correlations between the presence of blood or mucus in stool and detection of recognised dysenteric pathogens, and 
between duration of illness at time of presentation and the detection of any pathogen. 
 
Shigella and/or E. histolytica Any pathogen analysis 
Blood (n = 61) 21 NA p = 0.098 
No blood (n = 154) 36 NA (2 = 2.738, df = 1) 
Mucus (n = 81) 23 NA p = 0.626 
No mucus (n = 134) 34 NA (2 = 0.237, df = 1) 
 < 1 week (n = 111) NA 27 p = 0.02 
 > 1 week (n = 105) NA 41 (2 = 4.761, df = 1) 
For presence of blood or mucus in stools, one participant did not respond, thus total of 215 
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to have a pathogen detected than those with diarrhoea 
for less than a week (P = 0.02). Table 3 provides 
details of statistical analyses. 
 
Antibiotic Susceptibility Testing 
Both Shigella and S. Typhi were commonly 
resistant to ampicillin, tetracycline, co-trimoxazole 
and chloramphenicol. No isolates were resistant to 
ciprofloxacin or ceftriaxone, and only one S. Typhi 
isolate was resistant to nalidixic acid. Multiple 
resistance was common, with over half (26 of 47) of 
all Shigella isolates resistant to four antibiotics 
(ampicillin, tetracycline, co-trimoxazole and 
chloramphenicol). Antibiotic resistance data are 
provided in Table 4. 
Minimum inhibitory concentrations (MICs) were 
conducted on Shigella isolates, with MIC results 
corroborating disk diffusion results. High levels of 
resistance were commonly observed: for ampicillin, 16 
of 29 isolates tested had an MIC >256 µg/ml; for 
tetracycline, 10 of 25 isolates tested had an MIC >256 
µg/ml; for cotrimoxazole, 22 of 22 isolates tested had 
an MIC >32 µg/ml; and for chloramphenicol, 6 of 27 
isolates tested had an MIC >256 µg/ml. 
 
Discussion 
Our study highlights the importance of Shigella as 
an enteric pathogen in both children and adults in the 
highlands of PNG, with S. flexneri being the 
predominant species. This is the first study in the past 
25 years to seek multiple aetiologies in diarrhoeal 
cases in PNG, and the first such study in adults (to our 
knowledge). The importance of Shigella as an enteric 
pathogen in PNG reflects findings in other low-income 
settings. A recent study in both children and adults 
with diarrhoea in Ethiopia isolated Shigella from 
15.6% of participants, with enteric parasite co-
infections occurring in 18.3% of shigellosis cases [19]. 
In our study, Shigella and intestinal parasite co-
infections were observed in 10.6% of shigellosis cases. 
The isolation rate of Shigella in this study was 
higher than that of Howard and colleagues [5] in 
children in the same setting between 1985 and 1990 
(13%), although direct comparisons are difficult due to 
differences in study design and target age groups. 
However, our isolation rate in children less than 5 
years of age (19.5%) was higher than in symptomatic 
children in the study conducted by Howard et al. [5]. 
On the basis of these data, it would seem that the 
burden of Shigella has not diminished in PNG in the 
past 25 years. 
Approximately 20 years ago typhoid fever was 
highly endemic in the highlands of PNG, with an 
incidence rate among the highest in the world at that 
time [20]. A recent evaluation of typhoid fever 
diagnostic tests detected S. Typhi in ~8% of febrile 
patients [21]. It is well recognised that S. Typhi can be 
carried asymptomatically; thus it is not possible to 
ascertain whether S. Typhi was the cause of diarrhoea 
in our culture positive study participants. However, in 
this setting diarrhoea is commonly associated with 
typhoid fever, with a high proportion of confirmed 
typhoid fever positive patients in the recent diagnostic 
evaluation [21] self-reporting diarrhoea as a symptom 
(unpublished data). Regardless of whether S. Typhi 
contributed to diarrhoea, our data provide further 
evidence that S. Typhi continues to circulate in this 
population and contribute to the overall burden of 
enteric diseases.  
We did not detect any non-typhoid Salmonella 
Table 4. Proportion of Shigella spp and S. Typhi isolates resistant to antibiotics, and proportion of multiple-resistant strains. 
 
Shigella spp. 
n = 47 (%) 
Salmonella Typhi 
n = 5 (%) 
 
R I S R I S 
Ampicillin 43 (91.5) 0 (0) 4 (8.5) 4 (80) 0 (0) 1 (20) 
Tetracycline 36 (76.6) 0 (0) 11 (23.4) 3 (60) 0 (0) 2 (40) 
Co-trimoxazole 33 (70.2) 1 (2.1) 13 (27.7) 3 (60) 0 (0) 2 (40) 
Chloramphenicol 26 (55.3) 11 (23.4) 10 (21.3) 2 (40) 0 (0) 3 (60) 
Naladixic acid 0 (0) 0 (0) 47 (100) 1 (20) 0 (0) 4 (80) 
 
Multiple resistance Multiple resistance 
5 antibiotics 0 (0%) 1 (20%) 
4 antibiotics 26 (55.3%) 1 (20%) 
3 antibiotics 10 (21.3%) 1 (20%) 
2 antibiotics 7 (14.9%) 0 (0%) 
1 antibiotic 2 (4.3%) 1 (20%) 
Fully susceptible 2 (4.3%) 1 (20%) 
R - resistant; I - intermediate resistance; S - susceptible 
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(NTS) in this study. Salmonella are well recognised 
gastrointestinal pathogens, and NTS has become one 
of the most important pathogens in AIDS patients in 
sub-Saharan Africa. NTS has been detected in foods in 
lowland PNG [22], but it does not seem to play such a 
major role in enteric or febrile illness in highland 
PNG. The study conducted by Howard and colleagues 
detected Salmonella spp. in 4% of children with 
diarrhoea, most commonly in 3 – 11 year olds (9% 
isolation rate in cases). We had only 15 participants in 
that age range in our current study. A more recent 
study looking at the cause of mortality in children in 
this setting isolated Salmonella from 2 of 354 
participants [23]; however stool culture was not 
conducted in that study and those isolates were from 
blood or cerebral spinal fluid culture where the 
isolation rate of NTS would be expected to be lower. 
Nonetheless, our failure to isolate NTS is not 
appreciably different to that of previous findings in 
this setting. Moreover, we have not detected NTS in 
febrile patients in the general population [21] or in the 
HIV-positive population in this setting (unpublished 
data). 
Antibiotic resistance was common in Shigella spp. 
isolated in the current study. Almost all isolates 
(91.5%) were resistant to ampicillin, with resistance to 
tetracycline, co-trimoxazole and chloramphenicol also 
common. Every isolate that was resistant to 
chloramphenicol (26 of 47) was also resistant to the 
three other antibiotics above. These findings are 
consistent with recent observations in PNG and other 
low-income settings [24-27]. Multiple antibiotic 
resistance was also observed in S. Typhi. Moreover, 
two of the five isolates were resistant to 
chloramphenicol, the first line antibiotic for typhoid 
fever in PNG [28,29]. One S. Typhi isolate exhibited 
resistance to nalidixic acid. No Shigella isolates were 
resistant to ciprofloxacin or nalidixic acid, which is 
encouraging given the current national guidelines 
recommend ciprofloxacin as the first-line antibiotic for 
dysentery in cases were antibiotic therapy is required 
[28,29]. Globally there is increasing resistance to 
quinolones in Shigella spp. [30], thus ongoing 
surveillance in PNG is required.  
We detected parasites in 10.6% of participants. 
This detection rate is lower than in healthy pregnant 
women in the same area of PNG where comparable 
methods were used [31], and also lower than in a 
recent comparable study conducted in Ethiopia [19]. 
The true burden of parasites may not have been 
detected in this study. Wet preps are of most 
diagnostic value when conducted on fresh stools, 
while trophozoites are still motile [32]. Due to 
limitations in resources and capacity, stool samples 
could not be preserved (in sodium acetate-acetic acid-
formalin solution or similar) immediately following 
sample collection. Adding to the problem is the 
cultural reluctance to give stool samples in PNG: in 
most cases in this study rectal swabs were given rather 
than stools. Newer technologies, such as molecular 
based approaches, may be appropriate in low-income 
settings to determine the true prevalence of intestinal 
parasite infections. 
Pathogens were more commonly detected in adults 
than in children. This may be, in part, an artefact of the 
limited target organisms in this study. The burden of 
rotavirus in this setting has recently been reported [6], 
and other pathogens not targeted in this study are 
commonly associated with childhood diarrhoea, e.g. 
enteropathogenic Escherichia coli, isolated from 8% 
of cases by Howard et al. [5]. 
In this study we used molecular detection of the 
ipaH gene to confirm isolates as Shigella sp. This is a 
digression from the recognised practice of 
confirmation of Shigella through serology [33]. Using 
molecular methods we are unable to speciate Shigella 
as all four ‘species’ are genetically very similar. We 
found this method to be a viable alternative to 
traditional Shigella confirmatory testing in this setting 
which costs less to conduct per test (for a laboratory 
with the appropriate equipment). Although the ipaH 
gene is also present in enteroinvasive Escherichia coli 
(EIEC), this assay was used as a confirmatory test 
only, not for direct detection in stool samples. As such, 
we were able to rule out EIEC on the basis of colony 
morphology and biochemical tests.  
We did not detect evidence of ongoing 
transmission of cholera in the highlands of PNG. We 
have reported on the epidemiology of cholera in PNG 
elsewhere; with transmission occurring only in 
lowland and island regions of PNG [10]. However, 
this study did highlight the importance of Shigella in 
gastrointestinal illness in all age groups in the 
highlands of PNG. These findings support historical 
and recent data that demonstrate Shigella to be one of 
the most important gastrointestinal pathogens. 
Concerted efforts are required globally to lessen the 
burden of this pathogen.  
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